Therapeutic targets : modulation, inhibition, and activation

著者

書誌事項

Therapeutic targets : modulation, inhibition, and activation

edited by Luis M. Botana, Mabel Loza

John Wiley & Sons, c2012

大学図書館所蔵 件 / 全2件

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

The Latest Applications For Cellmechanism Research in Drug Discovery Designed to connect research on cell mechanisms with the drug discovery process, Therapeutic Targets: Modulation, Inhibition, and Activation introduces readers to a range of new concepts and novel approaches to drug screening and therapeutic drug targeting to help inform future avenues of drug research. Highly topical, this accessible edited volume features chapters contributed by respected experts from around the globe. The book helps postgraduate students and professional scientists working in academia and industry understand the molecular mechanisms of pharmacology, current pharmacological knowledge, and future perspectives in drug discovery, focusing on important biochemical protein targets and drug targeting strategies for specific diseases. Examining the pharmacology of therapeutically undefined targets and their potential applications, it includes chapters on traditional therapeutic targets, including enzymes (phosphodiesterases and proteases), ion channels, and G protein-coupled receptors, as well as more recently identified avenues of exploration, such as lipids, nuclear receptors, gene promoters, and more. Since different diseases require different targeting techniques, the book also includes dedicated chapters on strategies for investigating Alzheimer's, diabetes, pain, and inflammation treatments. Concluding with a cross-sectional look at new approaches in drug screening, Therapeutic Targets is an invaluable resource for understanding where the next generation of drugs are likely to emerge.

目次

Preface vii Contributors ix 1. cAMP-Specific Phosphodiesterases: Modulation, Inhibition, and Activation 1 R. T. Cameron and George S. Baillie 2. Protease-Activated Receptor 2 37 Qihai Gu and Lu-Yuan Lee 3. Voltage-Gated Sodium Channels as Therapeutic Targets 63 Joshua S. Wingerd, Irina Vetter, and Richard J. Lewis 4. Multitarget Drugs for Stabilization of Calcium Cycling and Neuroprotection in Neurodegenerative Diseases and Stroke 123 Antonio M. G. de Diego, Silvia Lorrio, Jesus M. Hernandez-Guijo, Luis Gandia, and Antonio G. Garcia 5. Oligomerization of G-Protein-Coupled Receptors 201 Juan F. Lopez-Gimenez and Javier Gonzalez-Maeso 6. Sigma 1 Receptor Chaperone: Pharmacology and Therapeutic Perspectives 225 Daniel Zamanillo, Enrique Portillo-Salido, Jose Miguel Vela, and Luz Romero 7. Lipids as New Targets 279 Eduardo Domunguez 8. Knowledge Base for Nuclear Receptor Drug Discovery 309 Albert A. Antolin and Jordi Mestres 9. Gene Promoters and Transcription Control Regions as Therapeutic Targets 327 Antonio Zorzano, David Sebastian, Jana Sanchez-Wandelmer, Laia Miret, and Fernando Albericio 10. Roles of Glucagon-Like Peptide and Glucose-Dependent Insolinotropic Polypeptide Hormones in Brain Function and Neurodegeneration 351 Christian Hoelscher 11. Exocytotic Machinery as a Target for the Development of New Drugs for Schizophrenia 375 Maria Jose Guerrero, Itsaso Hormaeche, Maria Uribarri, Julie Masse, and Jose Maria Palacios 12. Targeting Epigenetic Abnormalities in the Brain 409 Erin Y. Sterner, Lisa E. Kalynchuk, and Hector J. Caruncho 13. Rodent Models as Tools for Discovering Novel Therapeutic Targets in the Brain: The Case of Epilepsy 427 Justin J. Botterill, Axel J. Guskjolen, Lisa E. Kalynchuk, and Hector J. Caruncho 14. New Approaches Applied to Drug Screening 455 Jose Brea and Maria Isabel Loza Index 477

「Nielsen BookData」 より

詳細情報

ページトップへ